Suppr超能文献

探索膀胱癌患者的诊断体验和感受:一种混合方法研究。

Exploring patients' experience and perception of being diagnosed with bladder cancer: a mixed-methods approach.

机构信息

Division of Surgery and Interventional Science, University College London, London, UK.

Department of Urology, Northwick Park Hospital, London, UK.

出版信息

BJU Int. 2020 May;125(5):669-678. doi: 10.1111/bju.15008. Epub 2020 Feb 12.

Abstract

OBJECTIVE

To determine patient experience and perception following a diagnosis of non-muscle-invasive bladder cancer (NMIBC).

PATIENT AND METHODS

Patients were part of a prospective multicentre observational study recruiting patients with NMIBC for a urine biomarker study (DETECT II; ClinicalTrials.gov: NCT02781428). A mixed-methods approach comprising: (i) the Brief Illness Perception Questionnaire (Brief-IPQ) and (ii) semi-structured interviews to explore patients' experience of having haematuria, and initial and subsequent experience with a NMIBC diagnosis. Both assessments were completed at 6 months after NMIBC diagnosis.

RESULTS

A total of 213 patients completed the Brief-IPQ. Patients felt that they had minimal symptoms (median [interquartile range, IQR] score 2 [0-5]) and were not particularly affected emotionally (median [IQR] score 3 [1-6]) with a minimal effect to their daily life (median [IQR] score 2 [0-5]). However, they remained concerned about their cancer diagnosis (median [IQR] score 5 [3-8]) and felt that they had no personal control over the cancer (median [IQR] score 2 [2-5]) and believed that their illness would affect them for some time (median [IQR] score 6 [3-10]). A significant association with a lower personal control of the disease (P < 0.05) and a poorer understanding of the management of NMIBC (P < 0.05) was seen in patients aged >70 years. Many patients were uncertain about the cause of bladder cancer. Qualitative analysis found that at initial presentation of haematuria, most patients were not aware of the risk of bladder cancer. Patients were most anxious and psychologically affected between the interval of cystoscopy diagnosis and transurethral resection of bladder tumour (TURBT). Following TURBT, most patients were positive about their cancer prognosis.

CONCLUSION

Patients with NMIBC have a poor perception of disease control and believe that their disease will continue over a prolonged period of time. This is particularly more pertinent in the elderly. Patients are most psychologically affected during the interval between cancer diagnosis following cystoscopy and TURBT. Health awareness about bladder cancer remained poor with a significant number of patients unaware of the causes of bladder cancer. Psychological support and prompt TURBT following bladder cancer diagnosis would help improve the mental health of patients with NMIBC.

摘要

目的

确定非肌肉浸润性膀胱癌(NMIBC)诊断后患者的体验和感知。

患者和方法

患者是一项前瞻性多中心观察性研究的一部分,该研究招募了 NMIBC 患者进行尿液生物标志物研究(DETECT II;ClinicalTrials.gov:NCT02781428)。采用混合方法,包括:(i)简要疾病感知问卷(Brief-IPQ)和(ii)半结构化访谈,以探讨患者血尿的体验,以及初始和随后 NMIBC 诊断的体验。这两个评估都在 NMIBC 诊断后 6 个月完成。

结果

共有 213 名患者完成了 Brief-IPQ。患者认为他们的症状轻微(中位数[四分位距,IQR]评分 2[0-5]),情绪上的影响不大(中位数[IQR]评分 3[1-6]),日常生活的影响也不大(中位数[IQR]评分 2[0-5])。然而,他们仍然担心自己的癌症诊断(中位数[IQR]评分 5[3-8]),认为自己对癌症没有个人控制(中位数[IQR]评分 2[2-5]),并认为自己的疾病会在一段时间内对自己产生影响(中位数[IQR]评分 6[3-10])。在年龄大于 70 岁的患者中,观察到疾病个人控制程度较低(P<0.05)和对 NMIBC 管理理解较差(P<0.05)与较低的个人控制程度之间存在显著相关性。许多患者对膀胱癌的病因不确定。定性分析发现,在血尿初次出现时,大多数患者没有意识到膀胱癌的风险。在膀胱镜诊断和经尿道膀胱肿瘤切除术(TURBT)之间的间隔时间,患者最焦虑和受到心理影响。TURBT 后,大多数患者对癌症预后持积极态度。

结论

NMIBC 患者对疾病控制的感知较差,认为自己的疾病将持续很长一段时间。在老年人中,这种情况更为明显。患者在膀胱癌诊断后进行膀胱镜检查和 TURBT 之间的间隔时间内心理受影响最大。对膀胱癌的健康意识仍然很差,相当数量的患者不知道膀胱癌的病因。膀胱癌诊断后提供心理支持和及时的 TURBT 将有助于改善 NMIBC 患者的心理健康。

相似文献

1
Exploring patients' experience and perception of being diagnosed with bladder cancer: a mixed-methods approach.
BJU Int. 2020 May;125(5):669-678. doi: 10.1111/bju.15008. Epub 2020 Feb 12.
10
Does urinary cytology have a role in haematuria investigations?
BJU Int. 2019 Jan;123(1):74-81. doi: 10.1111/bju.14459. Epub 2018 Aug 29.

引用本文的文献

1
Illness perceptions in cochlear implant users - a longitudinal study.
Eur Arch Otorhinolaryngol. 2025 Feb;282(2):981-989. doi: 10.1007/s00405-024-08963-9. Epub 2024 Sep 19.
5
Patient experience of bladder cancer: A data linkage study.
BJUI Compass. 2024 Jan 31;5(3):382-388. doi: 10.1002/bco2.325. eCollection 2024 Mar.
6
Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs.
Front Oncol. 2023 Jun 2;13:1170124. doi: 10.3389/fonc.2023.1170124. eCollection 2023.
7
near-infrared targeted imaging of human bladder carcinoma by ICG-anti-CD47.
Front Oncol. 2023 Mar 1;13:1083553. doi: 10.3389/fonc.2023.1083553. eCollection 2023.
10
CD47-targeted optical molecular imaging and near-infrared photoimmunotherapy in the detection and treatment of bladder cancer.
Mol Ther Oncolytics. 2022 Jan 1;24:319-330. doi: 10.1016/j.omto.2021.12.020. eCollection 2022 Mar 17.

本文引用的文献

2
Cancer statistics, 2019.
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
3
Quality of Life in Non-Muscle-Invasive Bladder Cancer Survivors: A Systematic Review.
Cancer Nurs. 2019 May/Jun;42(3):E21-E33. doi: 10.1097/NCC.0000000000000606.
4
Can Renal and Bladder Ultrasound Replace Computerized Tomography Urogram in Patients Investigated for Microscopic Hematuria?
J Urol. 2018 Nov;200(5):973-980. doi: 10.1016/j.juro.2018.04.065. Epub 2018 Apr 24.
5
Who Should Be Investigated for Haematuria? Results of a Contemporary Prospective Observational Study of 3556 Patients.
Eur Urol. 2018 Jul;74(1):10-14. doi: 10.1016/j.eururo.2018.03.008. Epub 2018 Apr 10.
7
A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer.
Surg Oncol. 2016 Sep;25(3):281-97. doi: 10.1016/j.suronc.2016.05.027. Epub 2016 Jun 7.
8
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
Eur Urol. 2017 Mar;71(3):447-461. doi: 10.1016/j.eururo.2016.05.041. Epub 2016 Jun 17.
9
Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States, Europe and Asia.
Cancer Treat Rev. 2016 Jun;47:22-31. doi: 10.1016/j.ctrv.2016.05.002. Epub 2016 May 10.
10
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.
Eur Urol. 2016 Jul;70(1):106-119. doi: 10.1016/j.eururo.2016.02.028. Epub 2016 Mar 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验